Phibro Animal Health/$PAHC
13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1Y5YMAX
About Phibro Animal Health
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.
Ticker
$PAHC
Sector
Primary listing
Industry
Pharmaceuticals
Headquarters
Employees
1,940
ISIN
US71742Q1067
Website
PAHC Metrics
BasicAdvanced
$1.1B
35.88
$0.78
0.62
$0.48
1.71%
Price and volume
Market cap
$1.1B
Beta
0.62
52-week high
$28.49
52-week low
$16.16
Average daily volume
253K
Dividend rate
$0.48
Financial strength
Current ratio
2.912
Quick ratio
1.023
Long term debt to equity
280.002
Total debt to equity
289.49
Dividend payout ratio (TTM)
61.17%
Interest coverage (TTM)
3.57%
Profitability
EBITDA (TTM)
155.902
Gross margin (TTM)
32.27%
Net profit margin (TTM)
2.67%
Operating margin (TTM)
9.65%
Effective tax rate (TTM)
37.11%
Revenue per employee (TTM)
$610,000
Management effectiveness
Return on assets (TTM)
6.26%
Return on equity (TTM)
11.86%
Valuation
Price to earnings (TTM)
35.877
Price to revenue (TTM)
0.953
Price to book
4.27
Price to tangible book (TTM)
6.54
Price to free cash flow (TTM)
23.12
Free cash flow yield (TTM)
4.33%
Free cash flow per share (TTM)
121.11%
Dividend yield (TTM)
1.71%
Forward dividend yield
1.71%
Growth
Revenue change (TTM)
19.12%
Earnings per share change (TTM)
140.17%
3-year revenue growth (CAGR)
9.48%
10-year revenue growth (CAGR)
4.77%
3-year earnings per share growth (CAGR)
-18.64%
10-year earnings per share growth (CAGR)
-0.42%
10-year dividend per share growth (CAGR)
4.81%
What the Analysts think about PAHC
Analyst ratings (Buy, Hold, Sell) for Phibro Animal Health stock.
Bulls say / Bears say
Phibro Animal Health reported a significant 85% increase in Adjusted EBITDA for Q3 2025, indicating strong operational performance and potential for future growth. (investors.pahc.com)
The company's acquisition of Zoetis's Medicated Feed Additive portfolio has enhanced its market competitiveness and expanded its product offerings. (ainvest.com)
Phibro's stock price has shown a remarkable 101.19% increase over the past year, reflecting strong investor confidence and market performance. (fullratio.com)
The company's net income has declined by 93% year-over-year, raising concerns about profitability and financial health. (fullratio.com)
Phibro's debt-to-equity ratio has increased to 4.21 as of December 31, 2024, indicating higher financial leverage and potential risk. (macrotrends.net)
The company's limited international presence, with approximately 85% of revenue generated from North American markets, may restrict growth opportunities compared to global competitors. (dcfmodeling.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jun 2025.
PAHC Financial Performance
Revenues and expenses
PAHC Earnings Performance
Company profitability
PAHC News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Phibro Animal Health stock?
Phibro Animal Health (PAHC) has a market cap of $1.1B as of July 04, 2025.
What is the P/E ratio for Phibro Animal Health stock?
The price to earnings (P/E) ratio for Phibro Animal Health (PAHC) stock is 35.88 as of July 04, 2025.
Does Phibro Animal Health stock pay dividends?
Yes, the Phibro Animal Health (PAHC) stock pays dividends to shareholders. As of July 04, 2025, the dividend rate is $0.48 and the yield is 1.71%. Phibro Animal Health has a payout ratio of 61.17% on a trailing twelve-month basis.
When is the next Phibro Animal Health dividend payment date?
The next Phibro Animal Health (PAHC) dividend payment date is unconfirmed.
What is the beta indicator for Phibro Animal Health?
Phibro Animal Health (PAHC) has a beta rating of 0.62. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.